Stocks
Sarepta Therapeutics (SRPT) ROE US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | 5 years average | |||
| ROE, % | ? | -45.1% | -182.7% | -62.4% | 15.4% | -62.5% | 4.32% | ||
| Changes by years, y/y, % | +28pp | -138pp | +120pp | +78pp | -78pp | -67% | |||
Sarepta Therapeutics. ROE, %
Sarepta Therapeutics. ROE, changes, pp
Sarepta Therapeutics (SRPT) ROE US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| ROE, % | ? | -4.27% | -20.6% | -62.5% | 4.32% | -8.95% | 4.32% | |
| Changes by years, y/y, % | -9pp | -31pp | -78pp | +26pp | -5pp | |||
| Changes by quarters, q/q, % | +17pp | -16pp | -42pp | +67pp | -13pp | |||
